Other E3 ligases including IAP, VHL and RNF114 were also recruited by dasatinib-based PROTACs that achieved effective BCR-ABL degradation to suppress CML cells [89, 190, 192]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.